GSK3A and malignant colon neoplasm: We showed that GSK3α and GSK3β differ greatly in their binding proteins (Fig. 6E) and phospho-substrates (Fig. 4F) in colon cancer cells, although we cannot exclude the possibility that the phospho-substrates of GSK3α and GSK3β may differ in different cell types.